Could cannabis terpenes battle COVID-19? A recently conducted study examining the use of cannabis terpene formulation – NT-VRL on inflammatory conditions resulted in some extremely promising results in battling cytokine storm syndrome resulting from COVID-19.
Cytokine storm syndrome is a type of inflammatory reaction where white blood cells have been activated and release inflammatory cytokines, which the trigger white blood cells. The syndrome may cause symptoms such as fatigue, fever, and vomiting, but can progress to a point in which a patient may require a ventilator to stay alive or may perish.
Early results in the analysis, which happened in Israel, show that the terpene formula along with CBD is twice as capable of utilizing CBD on its own in addition to twice as successful as Dexamethasone, a typical corticosteroids remedy for swelling, Health Europa reports. This is promising results that showing cannabis terpenes battle COVID-19.
The analysis was completed by Eybna and Cannasoul, which declared they were working on the job together in April. NT-VRL is a patented formula of terpenes made by Eybna. The terpenes used in the formula were chosen especially for their own ant-viral and anti-inflammatory qualities.
The formula is made specifically for use via inhalation instead of in a pill or raw form.
“This kind of delivery process is a game-changer allowing us to attain curative qualities from such distinctive phytochemicals like never before,” Eybna’sCEO Nadav Eya stated in a prepared statement.
For the analysis, CBD and NT-VRL were each analyzed both in their own and utilized collectively, together with all the combo proving to be the best in these first tests. The analysis not only reveals the impact of Eybna’s particular terpene, but additionally that terpenes generally can have an impact on more than just taste and flavor.
The Israeli research is not the only one looking to the possible use of cannabis to help alleviate COVID-19 symptoms in addition to potentially stop somebody from accessing the virus in the first location.
Back in June, two Canadian investigators stated they believed a particular breed of cannabis may be useful inn the struggle against COVID-19 as a result of its capacity to prevent the virus from getting into the body via ACE2 receptors.
“Like other respiratory pathogens, SARS-CoV2 is transmitted via respiratory droplets, with possibility of aerosol and contact disperse. “Modulation of ACE2 amounts in these gateway cells may establish a plausible approach for diminishing disease susceptibility.”
The researchers, Olga and Igor Kovalchuck have allegedly been testing and developing a publication cannabis strain for decades, but with the aim of making a strain which helps combat inflammation and cancer. When the pandemic struck, the duo began to concentrate their efforts on the way in which the strain may be utilized to fight COVID-19.
“Working under the Health Canada study permit, we’ve developed over 800 fresh Cannabis sativa extracts and lines and hypothesized high-CBD C. sativa extracts might be utilized to regulate ACE2 expression in COVID-19 target cells.”
At the time of publication, the duo’s job was a concept as opposed to a confirmed truth; nonetheless, both studies point to cannabis possibly being a valuable source as the planet works towards discovering new therapies and possibly prevention methods for the Virus moving forward.